E-LIB Suche - Ergebnisse für: Di Rora A. G. L

1

Chromothripsis in acute myeloid leukemia: Biological featur..:

Fontana, M C ; Marconi, G ; Feenstra, J D M...
Leukemia. , 2017

Link: https://doi.org/10.1038/..

2

Pharmacological inhibition of wip1 sensitizes acute myeloid..:

Fontana M. C ; Nanni J ; Di Rora A. G. L...
info:eu-repo/semantics/altIdentifier/pmid/33917342. , 2021

Link: http://hdl.handle.net/11..

3

Synergism through WEE1 and CHK1 inhibition in acute lymphob..:

Di Rora A. G. L ; Bocconcelli M ; Ferrari A...
info:eu-repo/semantics/altIdentifier/pmid/31717700. , 2019

Link: http://hdl.handle.net/11..

4

Novel and rare fusion transcripts involving transcription f..:

Padella A ; Simonetti G ; Paciello G...
info:eu-repo/semantics/altIdentifier/pmid/31817495. , 2019

Link: http://hdl.handle.net/11..

5

Targeting the p53-MDM2 interaction by the small-molecule MD..:

Trino S ; Iacobucci I ; Erriquez D...
info:eu-repo/semantics/altIdentifier/pmid/26887044. , 2016

Link: http://hdl.handle.net/24..

6

Prexasertib, a Chk1/Chk2 inhibitor, increases the effective..:

di Rora A. G. L ; Iacobucci I ; Imbrogno E...
info:eu-repo/semantics/altIdentifier/pmid/27438145. , 2016

Link: http://hdl.handle.net/24..

7

Therapeutic implications of intratumor heterogeneity for TP..:

Derenzini E ; Iacobucci I ; Agostinelli C...
info:eu-repo/semantics/altIdentifier/pmid/26312160. , 2015

Link: http://hdl.handle.net/24..

8

In vitro and in vivo single-agent efficacy of checkpoint ki..:

I. Iacobucci ; A. G. L. Di Rorà ; M. V. V. Falzacappa...
info:eu-repo/semantics/altIdentifier/pmid/26542114. , 2015

Link: http://hdl.handle.net/24..

9

Constitutive activation of the DNA damage response pathway ..:

Derenzini E ; Agostinelli C ; Imbrogno E...
info:eu-repo/semantics/altIdentifier/pmid/25544753. , 2015

Link: http://hdl.handle.net/24..

10

In vitro and in vivo single-agent efficacy of checkpoint ki..:

Iacobucci, I ; Di Ror(`a), A. G. L ; Falzacappa, M. V. V...
info:eu-repo/semantics/altIdentifier/wos/WOS:000364366900002. , 2015

Link: https://hdl.handle.net/2..

11

The cell cycle checkpoint inhibitors in the treatment of le..:

Ghelli Luserna di Rora', A. ; Iacobucci, I. ; Martinelli, G.
Journal of Hematology & Oncology. 10 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

12

CDC20 in and out of mitosis: a prognostic factor and therap..:

Bruno S ; Ghelli Luserna di Rora A ; Napolitano R...
info:eu-repo/semantics/altIdentifier/pmid/35490245. , 2022

Link: https://hdl.handle.net/1..

13

Loss of PALB2 predicts poor prognosis in acute myeloid leuk..:

Padella A ; Fontana M. C ; Marconi G...
info:eu-repo/semantics/altIdentifier/pmid/33414401. , 2021

Link: http://hdl.handle.net/11..

14

Synthesis of Novel Tryptamine Derivatives and Their Biologi..:

Simonetti G ; Boga C ; Durante J...
info:eu-repo/semantics/altIdentifier/pmid/33525621. , 2021

Link: http://hdl.handle.net/11..

15

Bromodomain and extra-terminal motif proteins regulate line..:

M. Ghetti ; I. Vannini ; S. Bruno...
https://www.pagepress.org/journals/index.php/hr/article/view/8909. , 2020

Link: https://doaj.org/article..